CEO & Lab Head, EMO Biomedicine Corp.
BIOGRAPHY
MARCH, 2024 - MARCH, 2025
The experience of development and verification of analytical platforms for cellular and gene therapy (CGT) products in EMO Biomedicine
Speaker
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...